Abstract:Colorectal cancer (CRC) is influenced by perturbations in the colonic microbiota, characterized by an imbalance favoring pathogenic bacteria over beneficial ones. This dysbiosis contributes to CRC initiation and progression through mechanisms such as carcinogenic metabolite production, inflammation induction, DNA damage, and oncogenic signaling activation. Understanding the role of external factors in shaping the colonic microbiota is crucial for mitigating CRC progression. This study aims to elucidate the gut microbiome's role in CRC progression by analyzing paired tumor and mucosal tissue samples obtained from the colon walls of 17 patients. Through sequencing of the V3-V4 region of the 16S rRNA gene, we characterized the tumor microbiome and assessed its association with clinical variables. Our findings revealed a significant reduction in alpha diversity within tumor samples compared to paired colon biopsy samples, indicating a less diverse microbial environment within the tumor microenvironment. While both tissues exhibited dominance of similar bacterial phyla, their relative abundances varied, suggesting potential colon-specific effects. Fusobacteriota enrichment, notably in the right colon, may be linked to MLH1 deficiency. Taxonomy analysis identified diverse bacterial genera, with some primarily associated with the colon wall and others unique to this region. Conversely, several genera were exclusively expressed in tumor tissue. Functional biomarker analysis identified three key genes with differential abundance between tumor microenvironment and colon tissue, indicating distinct metabolic activities. Functional biomarker analysis revealed three key genes with differential abundance: K11076 (putrescine transport system) and K10535 (nitrification) were enriched in the tumor microenvironment, while K11329 (SasA-RpaAB circadian timing mediator) dominated colon tissue. Metabolic pathway analysis linked seven metabolic pathways to the microbiome. Collectively, these findings highlight significant gut microbiome alterations in CRC and strongly suggest that long-term dysbiosis profoundly impacts CRC progression.

The Composition of Colonic Commensal Bacteria According to Anatomical Localization in Colorectal Cancer

Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer

Analyze the Structure and Component Change of Colonized Bacterium in Colorectal Cancer Tissues

Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients

Microbiota Regulation of Inflammatory Bowel Disease and Colorectal Cancer

Disease-associated Gut Microbiome and Critical Metabolomic Alterations in Patients with Colorectal Cancer

Alterations of the Gut Microbiome and Fecal Metabolome in Colorectal Cancer: Implication of Intestinal Metabolism for Tumorigenesis

A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer

From colon wall to tumor niche: Unraveling the microbiome's role in colorectal cancer progression

Gut Microbiota Signatures in Tumor, Para-Cancerous, Normal Mucosa, and Feces in Colorectal Cancer Patients

Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer

Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer

Gut microbiome: decision-makers in the microenvironment of colorectal cancer

Colorectal cancer: role of commensal bacteria and bystander effects

The Crosstalk Between Intestinal Bacterial Microbiota and Immune Cells in Colorectal Cancer Progression

Progress in Research on Colorectal Cancer-Related Microorganisms and Metabolites

Gut Microbiota Alterations Are Distinct for Primary Colorectal Cancer and Hepatocellular Carcinoma

Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment

Three specific gut bacteria in the occurrence and development of colorectal cancer: a concerted effort

Gut microbiota in colorectal cancer: mechanisms of action and clinical applications

Mucosa-associated microbiota signature in colorectal cancer